Summary
Indomethacin, which is thought to exert its therapeutic effect by inhibiting the synthesis of PGE2, is a commonly used first-line agent in the treatment of rheumatoid arthritis (RA). However, the effect of this drug on the humoral immune response in RA remains unclear. In this study, modulation of the in vitro synthesis of IgM and IgM-rheumatoid factor (RF) by indomethacin and prostaglandin E2 was examined in 11 patients with active RA and 10 normal controls. Indomethacin at a final concentration of 1 μg/ml significantly enhanced IgM production (P<0.01) and RF production (P<0.02) inStaphylococcus aureus Cowan I (SAC) stimulated RA cultures when compared to controls in whom no net enhancement effect was observed. In the patients, this increase in IgM production was more pronounced than the corresponding increase in RF synthesis (P=0.078), suggesting that IgM and IgM-RF-secreting RA plasma cells have different susceptibilities to PGE2 mediated suppression. Nonetheless, addition of PGE2 (10−8 M final concentration) to the cultures inhibited IgM and RF production to a similar degree in the patient and control cultures. These findings demonstrate that PGE2 causes suppression of IgM and IgM auto-antibody production in vitro and that inhibition of endogenous PGE2 synthesis in RA patients treated with indomethacin results in a marked increase in the production of these antibodies.
Similar content being viewed by others
References
Hunder GG, Bunch TW (1982) Treatment of rheumatoid arthritis. Bull Rheum Dis 32: 1
Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 231: 232–235
Goodwin JS, Banknurst AD, Messner RP (1977) Suppression of human T-cell mitogenesis by prostaglandin. J Exp Med 146: 1719–1734
Thompson PA, Jelinek DF, Lipsky PE (1984) Regulation of human B cell proliferation by prostaglandin E2. J Immunol 133: 2446–2453
Jelinek DF, Thompson PA, Lipsky PE (1985) Regulation of human B cell activation by prostaglandin E2. J Clin Invest 75: 1339–1349
Snyder DS, Beller DI, Unanue ER (1982) Prostaglandins modulate macrophage Ia expression. Nature 299: 163–165
Hassan J, Feighery C, Bresnihan B, Whelan A (1989) Expression and regulation of the HLA-DR antigen on circulating monocytes isolated from patients with rheumatoid arthritis. Arthritis Rheum 32: 682–690
Hasler F, Bluestein H, Zvaifler N, Epstein L (1983) Analysis of the defects responsible for the impaired regulation of EBV-induced B cell proliferation by rheumatoid arthritis lymphocytes. J Exp Med 157: 173–188
Hasler F, Bluestein H, Zvaifler N, Epstein L (1983) Analysis of the defects responsible for the impaired regulation of EBV-induced B cell proliferation by rheumatoid arthritis lymphocytes. II. Role of monocytes and the increased sensitivity of rheumatoid arthritis lymphocytes to prostaglandin. J Immunol 131: 768–772
Tashjian AH, Voelkel EF, Levine L, Goldhaber P (1972) Evidence that the bone resorption stimulating factor produced by mouse fibrosarcoma cells is prostaglandin E2. J Exp Med 136: 1329
Ceuppens JL, Goodwin JS (1982) Endogenous PGE2 enhances polyclonal immunoglobulin production by tonically inhibiting T suppressor cell activity. Cell Immunol 70: 41–54
Staite ND, Panayi GS (1982) Regulation of human immunoglobulin production in vitro by PGE2. Clin Exp Immunol 49: 115–122
Alvarellos A, Lipsky PE, Jasin HE (1988) PGE2 modulation of rheumatoid factor synthesis. Arthritis Rheum 31: 1473–1480
Ropes MW, Bennett GA, Cobb S, Jacox R, Jessar RA (1958) Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 9: 175–176
Richie DM, Boyle JA, McInnes JM, Jasani MK, Dalakos TG, Grieveson P, Buchanan WW (1968) Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 37: 393–406
Steinbroker O, Traeger CH, Batterman RC (1949) Therapeutic criteria in rheumatoid arthritis. JAMA 140: 659–662
Boyum A (1968) Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 32 [Suppl]: 77
Hassan J, Hanly J, Bresnihan B, Feighery C, Whelan A (1986) The immunological consequence of gold therapy: a prospective study in patients with rheumatoid arthritis. Clin Exp Immunol 63: 614–620
Simkin NJ, Jelinek DF, Lipsky PE (1987) Inhibition of human B cell responsiveness by PGE2. J Immunol 138: 1076–1081
Jelinek DF, Lipsky PE (1987) Regulation of human B lymphocyte activation, proliferation and differentiation. Adv Immunol 40: 1
Karsh J, Goldstein R, Lazarovits (1989) In vitro IgM and IgM rheumatoid factor production in responce to SAC and PWM: the contribution of CD5+ (leu 1) B cells. Clin Exp Immunol 77: 179–183
Casali P, Burastero SE, Nakamura M, Inghirami G, Notkins AL (1987) Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1 + B cell subset. Science 236: 76–81
Hardy RR, Hayakawa K, Shimizu M, Yamasaki K, Kishimoto T (1987) Rheumatoid factor secretion from human Leu-1 + B cells. Science 236: 81–83
Wolinsky SI, Goodwin JS, Messner RP, Williams RC Jr (1980) Role of prostaglandin in the depressed cell-mediated immune response in rheumatoid arthritis. Clin Immunol Immunopathol 17: 31–37
Hassan J, Whelan A, Colohan H, Gannon M, Bloomfield EJ, Bresnihan B, Feighery C (1985) Monocyte suppression of the autologous mixed lymphocyte reaction in patients with rheumatoid arthritis. Ir J Med Sci 154: 413 (abstr)
Garcia-Penarrubia P, Bankhurst AD, Koster RT (1989) Prostaglandins from human T suppressor/cytotoxic cells modulate natural killer antibacterial activity. J Exp Med 170: 601–606
Okawa-Takasuji M, Aotsuka S, Uwatoko S, Yokohari R, Inagaki L (1988) Monocyte-mediate suppression of rheumatoid factor production in normal subjects. Clin Immunol Immunopathol 46: 195–204
Dayer JM, Krane SM, Goldring SR (1981) Cellular and humoral factors modulate connective tissue distruction and repair in arthritic diseases. Semin Arthritis Rheum 11 [Suppl 1]:77–81
Robinson DR, Curran DP, Hamer PJ (1982) Prostaglandins and related compounds in inflammatory rheumatic diseases. In: Ziff M, Velo P, Gorini S (eds) Advances in inflammation research, vol 3. Rheumatoid arthritis. Raven, New York, pp 17–28
Wernick RM, Lipsky PE, Marban-Arcos E, Maliakkal JJ, Edelbaum D, Ziff M (1985) IgG and IgM rheumatoid factor synthesis in rheumatoid synovial membrane cell cultures. Arthritis Rheum 28: 742–752
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hassan, J., Whelan, A., Bresnihan, B. et al. Induction of IgM and IgM-rheumatoid factor synthesis in vitro by indomethacin. Rheumatol Int 10, 235–239 (1991). https://doi.org/10.1007/BF02274885
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02274885